Sunomix Therapeutics
Sunomix Therapeutics is a privately held biopharmaceutical company pioneering the development of proprietary mRNA-LPN technology, Antibody Drug Conjugates Nanoparticules for the treatment of cancers and infectious diseases. Source (opens in a new tab)
- Headquarters
- US
- Provider types
- CRO, testing laboratory